Kokusai Co., Ltd. (TYO:7722)

G1 Therapeutics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	8,298	7,899	8,248	7,410	5,453	5,914
Cash & Short-Term Investments	8,298	7,899	8,248	7,410	5,453	5,914
Cash Growth	-10.61%	-4.23%	11.31%	35.89%	-7.80%	12.78%
Accounts Receivable	2,511	3,177	3,631	3,813	3,205	2,675
Other Receivables	-	10	56	52	34	33
Receivables	2,511	3,187	3,687	3,865	3,239	2,708
Inventory	4,492	4,289	3,501	3,780	3,135	4,330
Other Current Assets	281	489	356	383	314	455
Total Current Assets	15,582	15,864	15,792	15,438	12,141	13,407
Property, Plant & Equipment	2,848	2,872	2,868	2,950	3,000	3,101
Long-Term Investments	1,987	2,003	1,781	1,961	2,105	2,087
Other Intangible Assets	72	72	55	52	61	68
Long-Term Deferred Tax Assets	25	28	19	11	63	18
Other Long-Term Assets	2	1	2	1	1	1
Total Assets	20,516	20,840	20,517	20,413	17,371	18,690
Accounts Payable	1,732	1,514	1,963	1,902	1,322	2,405
Accrued Expenses	238	145	89	115	87	88
Short-Term Debt	750	970	1,340	1,600	1,432	1,320
Current Portion of Long-Term Debt	659	659	555	520	474	370
Current Income Taxes Payable	308	365	72	83	218	140
Other Current Liabilities	3,143	3,230	2,894	1,762	1,467	1,920
Total Current Liabilities	6,830	6,883	6,913	5,982	5,000	6,243
Long-Term Debt	1,615	1,780	2,119	2,666	570	789
Long-Term Deferred Tax Liabilities	70	130	73	94	103	144
Other Long-Term Liabilities	65	77	22	39	21	22
Total Liabilities	8,970	9,240	9,503	9,164	6,074	7,567
Common Stock	1,023	1,023	1,023	1,023	1,023	1,023
Additional Paid-In Capital	936	936	936	936	936	936
Retained Earnings	8,847	8,829	8,162	8,695	9,036	8,839
Treasury Stock	-461	-426	-327	-327	-327	-99
Comprehensive Income & Other	830	861	943	697	460	275
Total Common Equity	11,175	11,223	10,737	11,024	11,128	10,974
Minority Interest	371	377	277	225	169	149
Shareholders' Equity	11,546	11,600	11,014	11,249	11,297	11,123
Total Liabilities & Equity	20,516	20,840	20,517	20,413	17,371	18,690
Total Debt	3,024	3,409	4,014	4,786	2,476	2,479
Net Cash (Debt)	5,274	4,490	4,234	2,624	2,977	3,435
Net Cash Growth	-2.85%	6.05%	61.36%	-11.86%	-13.33%	-12.95%
Net Cash Per Share	389.17	329.86	307.97	190.86	214.59	244.36
Filing Date Shares Outstanding	13.51	13.47	13.75	13.75	13.75	14.08
Total Common Shares Outstanding	13.51	13.54	13.75	13.75	13.75	14.08
Working Capital	8,752	8,981	8,879	9,456	7,141	7,164
Book Value Per Share	827.32	829.04	780.97	801.84	809.41	779.49
Tangible Book Value	11,103	11,151	10,682	10,972	11,067	10,906
Tangible Book Value Per Share	821.99	823.72	776.97	798.06	804.97	774.66
Order Backlog	-	13,192	12,355	8,228	7,512	9,781

Source: S&P Global Market Intelligence. Standard template. Financial Sources.